Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
F Maggiolo, M Migliorino, R Maserati, A Pan… - Antiviral …, 2002 - journals.sagepub.com
Current antiretroviral drugs cannot eradicate HIV infections, and persons living with HIV are
often faced with very demanding daily therapeutic schedules that can induce poor …
often faced with very demanding daily therapeutic schedules that can induce poor …
[引用][C] Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
F MAGGIOLO, M MIGLIORINO… - Antiviral therapy …, 2001 - pascal-francis.inist.fr
Virological and immunological responses to a once-a-day antiretroviral regimen with
didanosine, lamivudine and efavirenz CNRS Inist Pascal-Francis CNRS Pascal and Francis …
didanosine, lamivudine and efavirenz CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz.
F Maggiolo, M Migliorino, R Maserati, A Pan, M Rizzi… - 2001 - cabidigitallibrary.org
Current antiretroviral drugs cannot eradicate HIV infections and persons living with HIV are
often faced with very demanding daily therapeutical schedules that can induce poor …
often faced with very demanding daily therapeutical schedules that can induce poor …
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
F Maggiolo, M Migliorino, R Maserati… - Antiviral …, 2001 - pubmed.ncbi.nlm.nih.gov
Current antiretroviral drugs cannot eradicate HIV infections, and persons living with HIV are
often faced with very demanding daily therapeutic schedules that can induce poor …
often faced with very demanding daily therapeutic schedules that can induce poor …
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz.
F Maggiolo, M Migliorino, R Maserati, A Pan… - Antiviral …, 2001 - europepmc.org
Current antiretroviral drugs cannot eradicate HIV infections, and persons living with HIV are
often faced with very demanding daily therapeutic schedules that can induce poor …
often faced with very demanding daily therapeutic schedules that can induce poor …
[PDF][PDF] Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
F Maggiolo, M Migliorino, R Maserati, A Pan… - Antiviral …, 2002 - researchgate.net
Two antiretroviral compounds are currently available as once-a-day drugs: efavirenz, a non-
nucleoside reverse transcriptase inhibitor with a long elimination half-life [6], and …
nucleoside reverse transcriptase inhibitor with a long elimination half-life [6], and …